申请人:Liu Kun
公开号:US20080119531A1
公开(公告)日:2008-05-22
Indoles of Formula I having —X-aryl-(CH
2)x
-oxazolidinedione and —X-heteroaryl-(CH
2)x
-oxazolidinedione substituents on the N atom of the indole ring, where x is 0 or 1, and —X— is a bond or —CH
2
—, and their thiazolidinedione analogs, are PPAR gamma agonists or partial agonists and are useful in the treatment and control of type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
式I的吲哚化合物在其N原子上具有—X-芳基-(CH2)x-噁唑烷二酮和—X-杂环芳基-(CH2)x-噁唑烷二酮取代基,其中x为0或1,—X—为键或—CH2—,它们的噻唑烷二酮类似物是PPAR gamma激动剂或部分激动剂,可用于治疗和控制II型糖尿病,包括与II型糖尿病常见相关的高血糖、失调脂质代谢、高脂血症、高胆固醇血症、高三酰甘油血症和肥胖症。